The prevention of prostate cancer--the dilemma continues

Editorial

Peter T Scardino. N Engl J Med. 2003.

. 2003 Jul 17;349(3):297-9.

doi: 10.1056/NEJMe038109. Epub 2003 Jun 24.

No abstract available

Comment in

A big study yields big questions.
Zuger A. Zuger A. N Engl J Med. 2003 Jul 17;349(3):213-4. doi: 10.1056/NEJMp038121. N Engl J Med. 2003. PMID: 12867605 No abstract available.
Prevention of prostate cancer with finasteride.
Roehrborn CG. Roehrborn CG. N Engl J Med. 2003 Oct 16;349(16):1569-72; author reply 1569-72. N Engl J Med. 2003. PMID: 14562804 No abstract available.
Prevention of prostate cancer with finasteride.
Schwartz DT. Schwartz DT. N Engl J Med. 2003 Oct 16;349(16):1569-72; author reply 1569-72. N Engl J Med. 2003. PMID: 14562808 No abstract available.

The influence of finasteride on the development of prostate cancer.
Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr. Thompson IM, et al. N Engl J Med. 2003 Jul 17;349(3):215-24. doi: 10.1056/NEJMoa030660. Epub 2003 Jun 24. N Engl J Med. 2003. PMID: 12824459 Clinical Trial.